Molecular pathways involved in the control of contractile and metabolic properties of skeletal muscle fibers as potential therapeutic targets for Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is caused by mutations in the gene encoding dystrophin, a subsarcolemmal protein whose absence results in increased susceptibility of the muscle fiber membrane to contraction-induced injury. This results in increased calcium influx, oxidative stress, and mitochondri...
        Saved in:
      
    
          | Main Authors: | Agnese Bonato, Giada Raparelli, Maurizia Caruso | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Frontiers Media S.A.
    
        2024-12-01 | 
| Series: | Frontiers in Physiology | 
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2024.1496870/full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Muscle Pathology Associated With Cardiac Function in Duchenne Muscular Dystrophy        
                          
 by: Jin A Yoon, et al.
 Published: (2024-12-01)
- 
                
                    Lipin1 as a therapeutic target for respiratory insufficiency of duchenne muscular dystrophy        
                          
 by: Alexandra Brown, et al.
 Published: (2024-11-01)
- 
                
                    Bone measurements interact with phenotypic measures in canine Duchenne muscular dystrophy        
                          
 by: Sarah M. Schneider, et al.
 Published: (2025-01-01)
- 
                
                    Wnt7a is required for regeneration of dystrophic skeletal muscle        
                          
 by: Uxia Gurriaran-Rodriguez, et al.
 Published: (2024-12-01)
- 
                
                    Effect of 2-Aminoethoxydiphenyl Borate on the State of Skeletal Muscles in Dystrophin-Deficient mdx Mice        
                          
 by: Mikhail V. Dubinin, et al.
 Published: (2024-12-01)
 
       